Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 21;12(3):212-223.
doi: 10.3390/audiolres12030024.

Audiovestibular Disorders after COVID-19 Vaccine: Is There an Association?

Affiliations
Review

Audiovestibular Disorders after COVID-19 Vaccine: Is There an Association?

Davide Pisani et al. Audiol Res. .

Abstract

The SARS-CoV-2 vaccination campaign is probably one of the most historic public hygiene measures in modern medicine. The drama of the pandemic has forced the scientific community to accelerate the development and commercialization of vaccines, thereby enhancing the phases of active surveillance. Among the adverse events following immunization (AEFI) reported, those of an audiovestibular interest, such as sudden sensorineural hearing loss (SSNHL), tinnitus, dizziness, and vertigo, constitute a very small percentage. There are many plausible etiological hypotheses, and scientific research needs to pay more attention to the correct collection of data, which up until now have often been inadequate and fragmented, on which to base future studies. SSNHL, new onset tinnitus, vertigo, and dizziness require a prompt evaluation, while the proposed treatment is the same as it is for events unrelated to vaccination. These are uncommon adverse events, and the risk rates for these diseases have not increased in conjunction with the COVID-19 vaccinations, therefore there is no justification of any hesitation towards the vaccination campaign.

Keywords: AEFI; COVID-19; SSNHL; adverse event; dizziness; tinnitus; vaccine; vertigo.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Ortega M.A., Fraile-Martínez O., García-Montero C., García-Gallego S., Sánchez-Trujillo L., Torres-Carranza D., Álvarez-Mon M.Á., Pekarek L., García-Honduvilla N., Bujan J., et al. An integrative look at SARS-CoV-2 (Review) Int. J. Mol. Med. 2021;47:415–434. doi: 10.3892/ijmm.2020.4828. - DOI - PMC - PubMed
    1. Perra N. Non-pharmaceutical interventions during the COVID-19 pandemic: A review. Phys. Rep. 2021;913:1–52. doi: 10.1016/j.physrep.2021.02.001. - DOI - PMC - PubMed
    1. Meyerowitz-Katz G., Bhatt S., Ratmann O., Brauner J.M., Flaxman S., Mishra S., Sharma M., Mindermann S., Bradley V., Vollmer M., et al. Is the cure really worse than the disease? The health impacts of lockdowns during COVID-19. BMJ Glob. Health. 2021;6:e006653. doi: 10.1136/bmjgh-2021-006653. - DOI - PMC - PubMed
    1. Kyriakidis N.C., López-Cortés A., González E.V., Grimaldos A.B., Prado E.O. SARS-CoV-2 vaccines strategies: A comprehensive review of phase 3 candidates. NPJ Vaccines. 2021;6:28. doi: 10.1038/s41541-021-00292-w. - DOI - PMC - PubMed
    1. Lundstrom K. The Current Status of COVID-19 Vaccines. Front. Genome Ed. 2020;2:579297. doi: 10.3389/fgeed.2020.579297. - DOI - PMC - PubMed

LinkOut - more resources